Inducible and conditional transgenic mouse models of schizophrenia

Progress in Brain Research

Volumn 179, Issue C, 2009, Pages 35-47

  Pletnikov, Mikhail V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; cAMP; DISC1; Dopamine; Genetics; Schizophrenia; Tet off system

Indexed keywords

DISC1 PROTEIN, HUMAN; DOPAMINE 2 RECEPTOR; ESTROGEN RECEPTOR ALPHA; GUANINE NUCLEOTIDE BINDING PROTEIN; NERVE PROTEIN; TETRACYCLINE;

ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; HUMAN; MOUSE; REVIEW; SCHIZOPHRENIA; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GTP-BINDING PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; TETRACYCLINE;

EID: 77953439115     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(09)17905-0     Document Type: Article

References (64)

1. Arnold, S. E., Talbot, K., & Hahn, C. G. (2005). Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Progressin Brain Research, 147, 319-345.
2. Ayhan, Y., Sawa, A., Ross, C. A., & Pletnikov, M. V. (2009). Animal models of gene-environment interactions in schizophrenia. Behavioural Brain Research, 204(2), 274-281.
3. Bach, M. E., Simpson, E. H., Kahn, L., Marshall, J. J., Kandel, E. R., & Kellendonk, C. (2008). Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning. Proceedings of the National Academy of Sciences of the United States of America, 105(41), 16027-16032.
4. Birrell, J. M., & Brown, V. J. (2000). Medial frontal cortex mediates perceptual attentional set shifting in the rat. Journal of Neuroscience, 20, 4320-4324.
5. Brandon, N. J., Handford, E. J., Schurov, I., Rain, J. C., Pelling, M., Duran-Jimeniz, B., et al. (2004). Molecularand Cellular Neurosciences, 25, 42-55.
6. Camargo, L. M., Collura, V., Rain, J. C., Mizuguchi, K., Hermjakob, H., Kerrien, S., et al. (2007). Disrupted in Schizophrenia 1 Interactome: Evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Molecular Psychiatry, 12(1), 74-86.
7. Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., & Millar, J. K. (2008). The DISC locus in psychiatric illness. Molecular Psychiatry, 13(1), 36-64.
8. Colacicco, G., Welzl, H., Lipp, H. P., & Wurbel, H. (2002). Attentional set-shifting in mice: Modification of a rat paradigm, and evidence for strain-dependent variation. Behavioural Brain Research, 132, 95-102.
9. Davidzon, G., Greene, P., Mancuso, M., Klos, K. J., Ahlskog, J. E., Hirano, M., et al. (2006). Early onset familial parkinsonism due to POLG mutations. Annals of Neurology, 59(5), 859 62.
10. Degenkolb, J, Takahashi, M., Ellestad, G. A., & Hillen, W. (1991). Structural requirements of tetracycline-Tet repressor interaction: Determination of equilibrium binding constants for tetracycline analogs with the Tet repressor. Antimicrobial Agents and Chemotherapy, 35, 1591-1595.
11. Drew, M. R., Simpson, E. H., Kellendonk, C, Herzberg, W. G., Lipatova, O., Fairhurst, S., et al. (2007). Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. Journal of Neuroscience, 27(29), 7731-7739.
12. Duan, X., Chang, J. H., Ge, S., Faulkner, R. L., Kim, J. Y., Kitabatake, Y., et al. (2007). Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell, 130(6), 1146-1158.
13. Eastwood, S. L. (2004). The synaptic pathology of schizophrenia: Is aberrant neurodevelopment and plasticity to blame. International Reviewof Neurobiology, 59, 47-72.
14. Gingrich, J. R., & Roder, J. (1998). Inducible gene expression in the nervous system of transgenic mice. Annual Review of Neuroscience, 21, 377-405.
15. Glantz, L. A., & Lewis, D. A. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archivesof General Psychiatry, 57(1), 65-73.
16. Gossen, M., & Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences of the United States of America, 89, 5547-5551.
17. Gossen, M, Freundlieb, S., Bender, G., Muller, G., Hillen, W., & Bujard, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science, 268, 1766-1769.
18. Hikida, T, Jaaro-Peled, H, Seshadri, S, Oishi, K, Hookway, C, Kong, S, et al. (2007). Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proceedings of the National Academy of Sciences of the United States of America, 104(36), 14501-14506.
19. Hillen, W, & Berens, C. (1994). Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annual Review of Microbiology, 48, 345-369.
20. Hillen, W., Klock, G., Kaffenberger, I., Wray, L. V., & Reznikoff, W. S. (1982). Purification of the TET repressor and TET operator from the transposon Tn10 and characterization of their interaction. Journal of Biological Chemistry, 257, 6605-6613.
21. Ishizuka, K., Paek, M., Kamiya, A., & Sawa, A. (2006). A review of Disrupted-In-Schizophrenia-1 (DISC1): Neurodevelopment, cognition, and mental conditions. Biological Psychiatry, 59(12), 1189-1197.
22. Kamiya, A., Kubo, K., Tomoda, T., Takaki, M., Youn, R., Ozeki, Y., et al. (2005). A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nature Cell Biology, 12, 1167-1178.
23. Kamiya, A., Tomoda, T., Chang, J., Takaki, M., Zhan, C., Morita, M., et al. (2006). DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1. Human Molecular Genetics, 15, 3313-3323.
24. Katsel, P., Davis, K. L., Li, C., Tan, W., Greenstein, E., Kleiner Hoffman, L. B., et al. (2008). Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology, 33(12), 2993-3009.
25. Kellendonk, C., Simpson, E. H., & Kandel, E. R. (2009). Modeling cognitive endophenotypes of schizophrenia in mice. Trends in Neurosciences, 32(6), 347-358.
26. Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winiger, V., et al. (2006). Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron, 49(4), 603-615.
27. Kelly, M. P., Stein, J. M., Vecsey, C. G., Favilla, C., Yang, X., Bizily, S. F., et al. (2009). Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia. Molecular Psychiatry, (4), 398-415.
28. Kessler, R. C., Amminger, G. P., Aguilar-Gaxiola, S., Alonso, J., Lee, S., & Ustün, T. B. (2007). Age of onset of mental disorders: A review of recent literature. Current Opinion in Psychiatry, 20(4), 359 64.
29. Kessler, R. C., Birnbaum, H., Demler, O., Falloon, I. R., Gagnon, E., Guyer, M., et al. (2005). The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biological Psychiatry, 58 (8), 668-676.
30. Kida, S., Josselyn, S. A., de Ortiz, S. P., Kogan, J. H., Chevere, I., Masushige, S., et al. (2002). CREB required for the stability of new and reactivated fear memories. Nature Neuroscience, 5, 348-355.
31. Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., et al. (1996). Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 93, 10933-10938.
32. Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., et al. (1996). Single photon emission computerized tomography imaging ofamphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences of the United States of America, 93, 9235-9240.
33. Lewis, D. A., & Levitt, P. (2002). Schizophrenia as a disorder of neurodevelopment. Annual Review of Neuroscience, 25, 409-432.
34. Li, W., Zhou, Y., Jentsch, J. D., Brown, R. A., Tian, X., Ehninger, D., et al. (2007). Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proceedings of the National Academy of Sciences of the United States of America, 104(46), 18280-18285.
35. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Davis, R. S., Davis, C. E., Lebowitz, B. D., Severe, J., & Hsiao, J. K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med, 353, 1209-1223.
36. Logie, C., & Stewart, F. (1995). Ligand-regulated site-specific recombination. Proceedings of the National Academy of Sciences of the United States of America, 92, 5940-5944.
37. Mallo, M. (2006). Controlled gene activation and inactivation in the mouse. Frontiers in Bioscience, 11, 313-327.
38. Marenco, S., & Weinberger, D. R. (2000). The neurodevelopmental hypothesis of schizophrenia: Following a trail of evidence from cradle to grave. Development and Psychopathology, 12(3), 501-527.
39. McKinney, B. C., Schneider, J. S., Schafer, G. L., Lowing, J. L., Mohan, S., Zhao, M. X., et al. (2008). Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter. Genes Brain and Behaviour, 7(2), 203-213.
40. Meisenzahl, E. M., Schmitt, G. J., Scheuerecker, J., & Möller, H. J. (2007). The role of dopamine for the pathophysiology of schizophrenia. International Reviewof Psychiatry, 19(4), 337-345.
41. Metzger, D., Clifford, J., Chiba, H., & Chambon, P. (1995). Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proceedings of the National Academy of Sciences of the United States of America, 92, 6991-6995.
42. Millar, J. K., Christie, S., Anderson, S., Lawson, D., Hsiao-Wei Loh, D., Devon, R. S., et al. (2001). Genomic structure and localization within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Molecular Psychiatry, 6(2), 173-178.
43. Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999). Mice with reduced NMD Areceptor expression display behaviors related to schizophrenia. Cell, 98(4), 427-436.
44. Morris, J. A., Kandpal, G., Ma, L., & Austin, C. P. (2003). DISC1 (Disrupted-In-Schizophrenia 1) is a centrosomeassociated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: Regulation and loss of interaction with mutation. Human Molecular Genetics, 12, 1591-1608.
45. Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., et al. (2004). Genes Brain and Behaviour, 3, 287-302.
46. Ozeki, Y., Tomoda, T., Kleiderlein, J., Kamiya, A., Bord, L., Fujii, K., et al. (2003). Proceedings of the National Academy of Sciences of the United States of America, 100, 289-294.
47. Pagsberg, A. K., Baaré, W. F., Raabjerg Christensen, A. M., Fagerlund, B., Hansen, M. B., Labianca, J., et al. (2007). Structural brain abnormalities in early onset first-episode psychosis. Journal of Neural Transmission, 114(4), 489-498.
48. Piscopo, P., Marcon, G., Piras, M. R., Crestini, A., Campeggi, L. M., Deiana, E., et al. (2008). A novel PSEN2 mutation associated with a peculiar phenotype. Neurology, 70(17), 1549-1554.
49. Pletnikov, M. V., Ayhan, Y., Nikolskaia, O., Xu, Y., Ovanesov, M. V., Huang, H., et al. (2008). Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Molecular Psychiatry, 13(2), 173-186.
50. Ross, C. A., Margolis, R. L., Reading, S. A., Pletnikov, M., & Coyle, J. T. (2006). Neurobiology of schizophrenia. Neuron, 52(1), 139-153.
51. Sawa, A., Pletnikov, M. V., & Kamiya, A. (2004). Neuron-glia interactions clarify genetic environmental links in mental illness. Trends in Neurosciences, 27(6), 294-297.
52. Shen, S., Lang, B., Nakamoto, C., Zhang, F., Pu, J., Kuan, S. L., et al. (2008). Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. Journalof Neuroscience, 28(43), 10893-10904.
53. Stieger, K., Belbellaa, B., Le Guiner, C., Moullier, P., & Rolling, F. (2009). In vivo gene regulation using tetracyclineregulatable systems. Advanced Drug Delivery Reviews, 61, 527-541.
54. Stone, M. H. (2006). History of schizophrenia and its antecedents. In JA Lieberman, S Stroup, & DO. Perkins (Eds.), Textbook of Psychiatry. American Psychiatric Publishing.
55. Straub, R. E., & Weinberger, D. R. (2006). Schizophrenia genes-famine to feast. Biological Psychiatry, 60(2), 81-83.
56. Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003). Schizophrenia as a complex trait: Evidence from metaanalysis of twin studies. Archivesof General Psychiatry, 60 (12), 1187-1192.
57. Vita, A., De Peri, L., Silenzi, C., & Dieci, M. (2006). Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies. Schizophrenia Research, 82(1), 75-88.
58. Weinberger, D. R. (1996). On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology, 14(3 Suppl), 1S-11S.
59. Woods, B. T. (1998). Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. American Journalof Psychiatry, 155(12), 1661-1670.
60. Wu, E. Q., Birnbaum, H. G., Shi, L., Ball, D. E., Kessler, R. C., Moulis, M., & Aggarwal, J. (2005). The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry, 66, 1122-1129.
61. Wu, E. Q., Shi, L., Birnbaum, H., Hudson, T., & Kessler, R. (2006). Annual prevalence of diagnosed schizophrenia in theUSA: A claims data analysis approach. Psychological Medicine, 36(11), 1535-1540.
62. Yamamoto, A., Lucas, J. J., & Hen, R. (2000). Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell, 101(1), 57-66.
63. Zhang, Y., Riesterer, C., Ayrall, A.-M., Sablitzky, F., Littlewood, T. D., & Reth, M. (1996). Inducible site directed recombination in mouse embryonic stem cells. Nucleic Acids Research, 24, 543-548.
64. Zhu,Z.,Zheng, T., Lee, C. G.,Homer, R. J.,&Elias, J.A. (2002). Tetracycline-controlled transcriptional regulation systems: Advances and application in transgenic animal modeling. Seminarsin Cell & Developmental Biology, 13(2), 121-128.